chartexchange

ADIL
Adial Pharmaceuticals, Inc
stockNASDAQ

At CloseOct 27, 2026 2:22:04 PM EDT
3.93USD+6.793%(+0.25)7,357
3.0100Bid4.7100Ask1.7000Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Charlottesville, VA, USA
Previous Close
$3.68
Beta
0.87
52-Week High
$9.53 2025-10-28
52-Week Low
$1.31 2026-05-15
SMA 50
$4.78
SMA 200
$3.25
Avg. Vol 10D
27,647
Avg. Vol 30D
37,020
Avg. Vol 90D
56,048
Relative Vol
0.19
2.11M
66.2200%
667
Nov 12, 2026 (16d)
Feb 6, 2026 · 1-for-25 (reverse)
ADIL Profile

adial pharmaceuticals is dedicated to personalized treatment for drug abuse and addiction. while our pipeline includes drug candidates for the treatment of opiate and amphetamine use, our two lead drug candidates are for the treatment of alcohol abuse. adial leverages its extensive knowledge of pharmacology and pharmacogenomics to change the paradigm of drug abuse treatment.

ADIL Performance
PeriodPriceDateChangeBeta
1W3.822026-10-20-2.09%-0.065
1M4.042026-09-28-7.43%0.216
3M2.812026-07-27+33.10%-0.866
6M1.562026-04-27+139.74%0.574
1Y9.122025-10-27-59.00%0.872
2Y26.002024-10-28-85.61%—
5Y2,025.002021-10-27-99.81%0.692
ADIL Stock Summary

Adial Pharmaceuticals, Inc (NASDAQ:ADIL) stock price today is $3.74, and today's volume is 6,894. ADIL is up 1.630% today. The 30 day average volume is 37,020. ADIL market cap is $9.82M with 2.63M shares outstanding.